Fig. 4. Inhibition of Fgf8 signaling disrupts pillar cell development.
(A) A control cochlear explant that was treated with a
function-blocking antibody directed against Fgf5. Stereocilia and cell
boundaries are labeled with phalloidin (green) and PCs with
anti-p75ntr (red). IHCs and first row OHCs are indicated.
(B) Cochlear explant treated with a function-blocking antibody that
binds to Fgf8 (labeling as in B). (C) ITO distances for control
(anti-Fgf5) and anti-Fgf8-treated explants at basal and midbasal regions of
the cochlear duct. *, P<0.001. Scale bar: 20 µm.